Fundraising Fox

Pure Bioscience

OTC: PURE

El Cajon, US · Founded 1992 · Delaware corporation · 29 employees on LinkedIn

Find your way into Pure Bioscience

43 people in our graph share verified history with the Pure Bioscience team — schools, employers, funds. One of them is your warm intro.

Richard Heymanunlockedknows Peter Wulff · together at Ligand Pharmaceuticals (overlapped)
×3knows the team · via Indiana University Bloomington
×4knows the team · via JenaValve Technology, Inc.
knows the team · via Pure Bioscience
×2knows the team · via Alphatec Spine
knows the team · via Ligand Pharmaceuticals

Pure Bioscience develops PURE Control, an FDA-approved antimicrobial processing aid that reduces pathogens in poultry and produce processing without affecting product quality or requiring label declarations. The product serves food processors seeking pathogen reduction during manufacturing.

BiotechCleantechFoodTechHealthtechNew Materials

Founders & leadership

ME
Mark ElliottExecutive
HR
Henry R. LambertExecutive
PWPeter Wulff
Peter WulffinChief Financial Officer and Chief Operating Officer2012–2015Peter Wulff is an executive officer at Pure Bioscience with over four decades of financial and operational management experience in the life sciences industry, including roles in publicly traded and privately held companies. He has led capital formation, business development, and international operations for growth-stage companies in the US and Europe.
RB
Robert BartlettPresident and Chief Executive Officer / Director

Board

DT
David Theno, Jr.Board director
GC
Gary CoheeBoard director
DP
Dave PfanzelterBoard director
TY
Tom Y. LeeBoard director
WO
William OtisBoard director
CC
Craig C. CulverBoard director

Reported raises · per SEC filings

Form D private placements

$20.4M disclosed across 6 rounds · 2014–2017

▶$337KraisedFeb 2017 · 5 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Gary CoheeDirector
  • Dave PfanzelterExecutive Officer, Director
  • Mark ElliottExecutive Officer
  • Henry R. LambertExecutive Officer, Director
  • David Theno, Jr.Director
  • Tom Y. LeeDirector
  • William OtisDirector
Offering amount
$337K
Amount sold
$337K
Minimum investment
$25K
Sales commissions
$28.6K
Placement agents
Garden State Securities, Inc.
First sale
Jan 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1MraisedDec 2016 · 7 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • William OtisDirector
  • Dave PfanzelterExecutive Officer, Director
  • David Theno, Jr.Director
  • Tom Y. LeeDirector
  • Henry R. LambertExecutive Officer, Director
  • Gary CoheeDirector
  • Mark ElliottExecutive Officer
Offering amount
$1M
Amount sold
$1M
Minimum investment
$25K
Sales commissions
$122K
Placement agents
Garden State Securities, Inc.
First sale
Dec 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedDec 2015 · 13 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Tom Y. LeeDirector
  • Mark ElliottExecutive Officer
  • Henry R. LambertExecutive Officer, Director
  • Gary CoheeDirector
  • William OtisDirector
  • Dave PfanzelterExecutive Officer, Director
  • David Theno, Jr.Director
Offering amount
$2M
Amount sold
$2M
First sale
Nov 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6MraisedOct 2015 · 1 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • David Theno, Jr.Director
  • Gary CoheeDirector
  • Dave PfanzelterDirector
  • Mark ElliottExecutive Officer
  • Tom Y. LeeDirector
  • William OtisDirector
  • Henry R. LambertExecutive Officer, Director
Offering amount
$6M
Amount sold
$6M
First sale
Oct 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$9.9MraisedSep 2014 · 28 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Gary CoheeDirector
  • Peter C. WulffExecutive Officer
  • Dave PfanzelterDirector
  • William OtisDirector
  • David Theno, Jr.Director
  • Henry R. LambertExecutive Officer, Director
Offering amount
$9.9M
Amount sold
$9.9M
First sale
Aug 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.1MraisedMar 2014 · 15 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • David Theno, Jr.Director
  • Henry R. LambertExecutive Officer, Director
  • Peter WulffExecutive Officer
  • William OtisDirector
  • Dave PfanzelterExecutive Officer, Director
  • Craig C. CulverDirector
  • Gary CoheeDirector
Offering amount
$5M
Amount sold
$1.1M
First sale
Jan 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
Brainly48 shared keywordsBrainly provides 1:1 tutoring combining AI explanations with human expert intervention, targeting K-12 students and their parents seeking affordable academic support across all subjects. The platform emphasizes guaranteed grade improvement within 30 days, safety through human supervision of AI interactions, and compliance with education-focused privacy standards.

Companies competing with Pure Bioscience for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Pure Bioscience | El Cajon Asset Manager | Altssaltss.com · Jun 2026

Frequently asked questions

What does Pure Bioscience do?
Pure Bioscience develops PURE Control, an FDA-approved antimicrobial processing aid that reduces pathogens in poultry and produce processing without affecting product quality or requiring label declarations. The product serves food processors seeking pathogen reduction during manufacturing.
How much funding has Pure Bioscience raised?
Pure Bioscience has disclosed $20.4M raised across 6 rounds.
Where is Pure Bioscience headquartered?
Pure Bioscience is headquartered in El Cajon, US.